ANG Lifesciences India Limited
BSE: ANG
Prev Close
28.98
Open Price
28.5
Volume
300
Today Low / High
28.38 / 29.5
52 WK Low / High
21.03 / 46
Range
28 - 31
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 29.5, reflecting a change of 0.52 (1.79434%). The expected target range on the BSE is 28 - 31. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
ANG Lifesciences India Limited Graph
ANG Lifesciences India Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for ANG Lifesciences India Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 29.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 29.50 | 29.80 | 26.82 - 32.77 |
| 30.09 | 24.07 - 36.11 | ||
| 30.39 | 21.27 - 39.50 | ||
| Bearish Scenario | 29.50 | 29.21 | 26.28 - 32.13 |
| 28.91 | 23.13 - 34.69 | ||
| 28.62 | 20.03 - 37.20 |
Overview of ANG Lifesciences India Limited
ISIN
INE236W01016
Industry
Medical - Pharmaceuticals
Vol.Avg
6,632
Market Cap
385,219,467
Last Dividend
0
Official Website
IPO Date
DCF Diff
8.50
DCF
20
Financial Ratios Every Investor Needs
Stock Dividend of ANG
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2021-11-02 | November 02, 21 | 0.8 | 1 | 2021-11-04 | 2021-11-24 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 92.85 Cr | 59.62 Cr | 33.22 Cr | 0.3578 | 0.00 Cr | 0.00 Cr | -9.03 Cr | -12.41 Cr | -9.52 | -0.26 Cr | -0.1337 |
| 2024-03-31 | 146.01 Cr | 95.11 Cr | 50.90 Cr | 0.3486 | 0.00 Cr | 19.68 Cr | 2.73 Cr | -10.14 Cr | -7.81 | 8.62 Cr | -0.0695 |
| 2023-03-31 | 219.78 Cr | 150.59 Cr | 69.19 Cr | 0.3148 | 0.00 Cr | 0.71 Cr | 6.81 Cr | -0.26 Cr | -0.20 | 23.17 Cr | -0.0012 |
| 2022-03-31 | 354.12 Cr | 227.98 Cr | 126.14 Cr | 0.3562 | 0.25 Cr | 2.40 Cr | 62.48 Cr | 40.32 Cr | 31.11 | 67.72 Cr | 0.1138 |
| 2021-03-31 | 153.90 Cr | 103.96 Cr | 49.94 Cr | 0.3245 | 0.00 Cr | 0.54 Cr | 14.15 Cr | 7.03 Cr | 5.42 | 14.53 Cr | 0.0457 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.16 Cr | 229.59 Cr | 165.62 Cr | 63.9759 Cr | 83.21 Cr | 83.05 Cr | 54.11 Cr | 57.19 Cr | 0.00 Cr | 0.00 Cr | 0.03 Cr | 143.4364 Cr |
| 2024-03-31 | 0.32 Cr | 242.44 Cr | 166.16 Cr | 76.2774 Cr | 72.84 Cr | 72.52 Cr | 47.77 Cr | 58.40 Cr | 0.00 Cr | 0.00 Cr | -5.17 Cr | 144.5666 Cr |
| 2023-03-31 | 0.32 Cr | 277.66 Cr | 191.44 Cr | 86.2177 Cr | 70.75 Cr | 70.42 Cr | 48.49 Cr | 88.38 Cr | 4.99 Cr | 0.00 Cr | 0.03 Cr | 162.2840 Cr |
| 2022-03-31 | 0.35 Cr | 291.03 Cr | 207.26 Cr | 83.7691 Cr | 77.00 Cr | 76.65 Cr | 36.96 Cr | 92.85 Cr | 4.09 Cr | 0.00 Cr | -5.40 Cr | 166.2893 Cr |
| 2021-03-31 | 3.86 Cr | 143.65 Cr | 102.07 Cr | 41.5831 Cr | 43.16 Cr | 39.30 Cr | 19.26 Cr | 23.86 Cr | 1.26 Cr | 2.95 Cr | 3.52 Cr | 91.5613 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.2555 Cr | -1.5874 Cr | 1.6817 Cr | -4.0069 Cr | -0.1612 Cr | 0.1573 Cr | -3.7514 Cr | -15.7037 Cr | 11.1878 Cr | 0.0000 Cr | -6.3432 Cr |
| 2024-03-31 | -9.4947 Cr | 19.8917 Cr | -10.4027 Cr | -15.0632 Cr | -0.0057 Cr | 0.3185 Cr | -5.5685 Cr | -10.7131 Cr | 1.3061 Cr | 0.0000 Cr | 0.7211 Cr |
| 2023-03-31 | 26.3772 Cr | -9.3250 Cr | -17.0740 Cr | 15.9327 Cr | -0.0218 Cr | 0.3242 Cr | -10.4445 Cr | 2.6250 Cr | -7.0152 Cr | 0.0000 Cr | -11.5280 Cr |
| 2022-03-31 | 24.7172 Cr | -44.4099 Cr | 19.9276 Cr | -16.6276 Cr | 0.2349 Cr | 0.3460 Cr | -41.3448 Cr | 53.5005 Cr | 28.9216 Cr | -1.0353 Cr | -17.7004 Cr |
| 2021-03-31 | 9.1440 Cr | -7.6952 Cr | -1.1864 Cr | 4.8996 Cr | 0.2624 Cr | 3.8630 Cr | -4.2444 Cr | 7.0276 Cr | 1.7793 Cr | 0.0000 Cr | -9.2544 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 26.05 Cr | 17.84 Cr | 8.21 Cr | 0.3152 | -1.44 Cr | -2.95 Cr | -2.26 | 0.20 Cr | -0.1131 |
| 2025-06-30 | 24.60 Cr | 16.22 Cr | 8.38 Cr | 0.3406 | -0.88 Cr | -2.01 Cr | -1.52 | 0.73 Cr | -0.0815 |
| 2025-03-31 | 16.82 Cr | 10.45 Cr | 6.37 Cr | 0.3789 | -2.12 Cr | -2.06 Cr | -1.58 | -0.05 Cr | -0.1225 |
| 2024-12-31 | 24.73 Cr | 16.05 Cr | 8.68 Cr | 0.3509 | -4.11 Cr | -5.19 Cr | -3.98 | -2.42 Cr | -0.2099 |
| 2024-09-30 | 32.88 Cr | 21.45 Cr | 11.43 Cr | 0.3476 | 0.55 Cr | -2.09 Cr | -1.53 | 2.64 Cr | -0.0635 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.13 Cr | 13.24 Cr | 13.37 Cr | 87.11 Cr | 50.61 Cr | 181.44 Cr | 53.78 Cr | 243.26 Cr | 184.26 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 3.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -63.98 Cr |
| 2025-03-31 | 0.16 Cr | 3.48 Cr | 13.28 Cr | 66.54 Cr | 54.11 Cr | 165.34 Cr | 57.19 Cr | 229.59 Cr | 165.62 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 3.96 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -71.20 Cr |
| 2024-09-30 | 0.35 Cr | 14.65 Cr | 15.00 Cr | 69.42 Cr | 53.12 Cr | 178.60 Cr | 58.89 Cr | 242.29 Cr | 171.09 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | -2.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | -2.06 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | -5.19 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -2.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -3.07 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2022-07-13 | July 13, 22 | 5:4 |
| 2021-09-22 | September 22, 21 | 2:1 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹820.35 | ₹98,251,429,414.00 | ₹74,763.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born: 1972
Gender: female
Year Born:
Gender: female
Year Born: 1977
FAQs about ANG Lifesciences India Limited
The CEO is Rajesh Gupta.
The current price is ₹29.50.
The range is ₹21.03-46.
The market capitalization is ₹38.52 crores.
The P/E ratio is -3.16.
The company operates in the Healthcare sector.
Overview of ANG Lifesciences India Limited (ISIN: INE236W01016) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹38.52 crores and an average daily volume of 6,632 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.